About Larvol
Larvol is a company based in San Francisco (United States) founded in 2004 by Bruno Larvol. It operates as a SaaS and B2B. Larvol offers products and services including CLIN, PULSE, CONF, REDRAW, and IMPACT. Larvol operates in a competitive market with competitors including Definitive Healthcare, ESO, Molecular Connections, Collaborative Drug Discovery and Borderless Access, among others.
- Headquarter San Francisco, United States
- Founders Bruno Larvol
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Larvol
Larvol offers a comprehensive portfolio of products and services, including CLIN, PULSE, CONF, REDRAW, and IMPACT.
Tool for searching cancer trials and results data.
Service for reports on drug trends and industry updates.
Platform for organizing and recapping medical events.
Service for redrawing clinical trial figures.
Tool for analyzing themes from oncology opinion leaders.
People of Larvol
Unlock access to complete
Funding Insights of Larvol
Detailed funding history for Larvol
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Larvol
Investment portfolio details for Larvol
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Larvol
Detailed financials for Larvol
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Larvol Comparisons
Peer comparison for Larvol
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Larvol
Larvol operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Definitive Healthcare, ESO, Molecular Connections, Collaborative Drug Discovery and Borderless Access, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Offers market intelligence and data analytics for healthcare providers and physicians
|
|
| Locked | Locked | Locked |
EHR platform for emergency services is provided.
|
|
| Locked | Locked | Locked |
Databases and analytics for drug discovery are provided.
|
|
| Locked | Locked | Locked |
Biological and chemical data are managed securely in a database.
|
|
| Locked | Locked | Locked |
Analytics-driven sampling suite for healthcare market research is offered.
|
|
| Locked | Locked | Locked |
Patient-level healthcare data solutions are provided to pharmaceutical sectors.
|
Detailed competitors of Larvol
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Larvol
Complete news archive for Larvol
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Larvol
Larvol was founded in 2004.
Larvol is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Bruno Larvol is the current CEO of Larvol. They have also founded this company.
LARVOL delivers a platform for aggregating cancer trial data, AI-driven analysis, and market intelligence tools. It focuses on tracking clinical trials, key opinion leaders, and industry trends through services like CLIN, PULSE, and CONF. Based in San Francisco, it serves pharmaceutical and biotech firms by offering curated data, conference planning, and trend reports to support oncology research and decision-making.
Larvol's top competitors include Definitive Healthcare, ESO and Borderless Access.
Larvol offers CLIN, PULSE, CONF, REDRAW, and IMPACT.